4-83301038-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001098540.3(HPSE):c.1394G>A(p.Arg465Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000398 in 1,606,306 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001098540.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPSE | NM_001098540.3 | c.1394G>A | p.Arg465Gln | missense_variant | 11/12 | ENST00000311412.10 | NP_001092010.1 | |
HPSE | NM_006665.6 | c.1394G>A | p.Arg465Gln | missense_variant | 12/13 | NP_006656.2 | ||
HPSE | NM_001199830.1 | c.1220G>A | p.Arg407Gln | missense_variant | 10/11 | NP_001186759.1 | ||
HPSE | NM_001166498.3 | c.1172G>A | p.Arg391Gln | missense_variant | 10/11 | NP_001159970.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPSE | ENST00000311412.10 | c.1394G>A | p.Arg465Gln | missense_variant | 11/12 | 1 | NM_001098540.3 | ENSP00000308107 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152026Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000603 AC: 15AN: 248718Hom.: 0 AF XY: 0.0000743 AC XY: 10AN XY: 134534
GnomAD4 exome AF: 0.0000433 AC: 63AN: 1454280Hom.: 0 Cov.: 27 AF XY: 0.0000553 AC XY: 40AN XY: 723884
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152026Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74254
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at